North American Cannabis Index Jumps 86% in 2017

Analysis originally distributed on January 3, 2018 By: Michael Vodicka of Cannabis Stock Trades

2017 turned out to be a great year for cannabis stocks - particularly if you knew which stocks to buy.

The North American Cannabis Index was up 86% in 2017.

North American Marijuana Index

Canadian stocks were on fire - the Canadian Cannabis Index was up 160% in 2017.

Canadian Marijuana Index

Most improved award goes to US cannabis stocks - they were steadily falling for most of the year - down 40% on the year in late October.

Then in early November, a major rally kicked in and US cannabis stocks rallied hard - with the US cannabis index jumping more than 100% from the 52-week low. Continue reading "North American Cannabis Index Jumps 86% in 2017"

2 Profit Triggers Could Send This Stock Soaring In 2018

Analysis originally distributed on Decemberber 20, 2017 By: Michael Vodicka of Cannabis Stock Trades

Last week I shared a list of 6 cannabis stocks I expect to profit from the legalization of recreational cannabis in California.

This week I am going to take a deeper dive into one of my favorite stocks from the list.

  • This is a good stock to profit from California
  • It's also a broad play on the US cannabis sector
  • Third-quarter sales were up 86% from last year
  • Shares just spiked into a 52-week high
  • I see plenty more gains ahead.

GrowGeneration (OTC:GRWG) is a US cannabis company headquartered in Denver, Colorado.

Shares are traded in US, OTC markets under the ticker symbol GRWG.

GrowGeneration owns and operates specialty retail hydroponic and organic gardening stores. Currently, GrowGen has 13 stores, which includes 9 locations in Colorado, 2 locations in California, 1 in Las Vegas and 1 location in Seattle.

GrowGen carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers. Continue reading "2 Profit Triggers Could Send This Stock Soaring In 2018"

Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs

Analysis originally distributed on August 23, 2016 By: Michael Vodicka of Cannabis Stock Trades

MGC Pharmaceuticals (TSX:MXC, OTC:MGCLF) is a young cannabis biotech headquartered in Western Australia that specializes in pharmaceutical product research and development.

MGC

Australian cannabis stocks have been red hot for the last few months.

  • I added Australian-based Cann Group (ASX:CAN) to the members portfolio on July 31 and we're already up 70% in less than three weeks.
  • I added fellow Australian cannabis stock AusCann (OTC:ACNNF) to the member portfolio on June 6 and we're up 55%.

If you want to learn more about our member portfolio click here.

Although the company is incorporated and headquartered in Australia it also has operations in both Israel and Europe.

For example, MGC received two licenses from the Slovenian government to grow, process and trade Cannabis Sativa L (Hemp) and its products, including Cannabidoil (CBD) resin, in Europe.

The company's founders were leaders in Israel's growing medical cannabis industry. Continue reading "Australian Cannabis Biotech Developing Cancer and Epilepsy Drugs"

Cann Group Up 81% In 3 Weeks

Analysis originally distributed on August 16, 2017 By: Michael Vodicka of Cannabis Stock Trades

This week, I want to share AusCann Group Holdings Ltd. (NASDAQ:ACNNF)/ Cann Group (ASX:CAN) with the free newsletter crowd.

This is a stock I rolled out to members two weeks ago as one of our most recent trades. Members will always get the first look at the best ideas and information we have to offer at CST.

Since being added to the CST portfolio, Cann Group has been surging - Cannabis Stock Trades members are up around 75% on this trade.

2nd Australian Cannabis Permit Holder up 99% in 15 Days - More to Come?

Medical cannabis became legal in Australia in November of 2016.

Under the new program, companies interested in entering the industry must apply for and receive a permit from federal regulators to grow and sell cannabis. Continue reading "Cann Group Up 81% In 3 Weeks"

Warren Buffet Would Love This Cannabis Stock

Analysis originally distributed on July 27, 2017 By: Michael Vodicka of Cannabis Stock Trades

In early 2017 Forbes ranked Warren Buffett as the world’s second richest man with a net worth of $72 billion.

Unlike most other billionaires on the list, Buffett didn’t get rich from owning just one company. Berkshire Hathaway Inc. (NYSE:BRK.B) functioned like a giant mutual fund, investing in many companies from different industries all across the economy. That way, if one industry or company struggled, it wouldn’t crush Berkshire’s performance.

At the core, this is a lesson in diversification. Putting all your eggs in one basket can be risky.

That is particularly true in the cannabis sector. It is a super young industry and cannabis stocks can be quite volatile.

I want to share a cannabis stock that Warren Buffett would love. Continue reading "Warren Buffet Would Love This Cannabis Stock"